Protein and peptide sensors using electrical detection methods

• US 6,824,669 B1
• Filed: 02/17/2000
• Issued: 11/30/2004
• Est. Priority Date: 02/17/2000
• Status: Expired due to Term

• Current Assignee: Osmetech Technology Inc. (Roche Holding AG)
• Original Assignee: Motorola, Inc. (Motorola Solutions, Inc.)
• Inventors: Zhang, Peiming, Li, Changming, Sawyer, Jaymie Robin, Choong, Vi-En, Maracas, George
• Primary Examiner(s): Olsen, Kaj K.
• Application Number:
  US09/506,178
• Time in Patent Office: 1,748 Days
• Field of Search: 205/775, 205/777.5, 205/792, 204/403.01, 204/403.13, 204/412, 324/600, 324/658, 324/663, 324/691, 324/692, 435/6, 435/7.1, 435/7.2, 422/82.01, 422/82.02
• US Class Current: 205/777.5
• CPC Class Codes: G01N 33/5438 Electrodes

Abstract

The present invention provides an apparatus and methods for the electrical detection of molecular interactions between a probe molecule and a protein or peptide target molecule, but without requiring the use of electrochemical or other reporters to obtain measurable signals. The methods can be used for electrical detection of molecular interactions between probe molecules bound to defined regions of an array and protein or peptide target molecules which are permitted to interact with the probe molecules.

Claims

1. A method of electrically detecting a molecular interaction between an immobilized probe molecule and a protein or peptide target molecule, comprising:

(a) detecting a first electrical signal in one or a plurality of microelectrodes in contact with linker moieties to which probe molecules are immobilized,

(b) exposing said one or a plurality of microelectrodes to a sample mixture containing a protein or peptide target molecule,

(c) detecting a second electrical signal in said one or a plurality of microelectrodes,

(d) comparing said first electrical signal with said second electrical signal,

(e) determining whether said first electrical signal is different from said second electrical signal,

(f) exposing said one or a plurality of microelectrodes to one or a plurality of target binding molecules comprising an electrochemical label,

(g) detecting a third electrical signal in said one or a plurality of microelectrodes, and

(h) comparing said second electrical signal with said third electrical signal.

2. The method of claim 1, wherein said molecular interaction is detected by a method selected from the group consisting of impedance spectroscopy, cyclic voltammetry, AC voltammetry, pulse voltammetry, square wave voltammetry, hydrodynamic modulation voltammetry, conductance, potential step method, potentiometric measurements, amperometric measurements, current step method, other steady-state and transient measurement methods, and combinations thereof.

3. The method of claim 1, wherein said molecular interaction is detected by AC impedance measured over a range of frequencies.

4. The method of claim 1, wherein said molecular interaction is detected by AC impedance measured by a transient method with AC signal perturbation superimposed upon a DC potential applied to an electrochemical cell.

5. The method of claim 1, wherein said molecular interaction is detected by AC impedance measured by an impedance analyzer, lock-in amplifier, AC bridge, AC voltammetry, or combinations thereof.

6. The method of claim 1, wherein said linker moieties comprise polyacrylamide gel, agarose gel, polyethylene glycol, cellulose gel, sol gel, or combinations thereof.

7. The method of claim 1, wherein said target binding molecules are oligonucleotides or nucleic acids.

8. The method of claim 1, wherein said target binding molecules are aptamers.

9. The method of claim 1, wherein said target binding molecules are proteins or peptides.

10. The method of claim 9, wherein said proteins or peptides are antibodies.

11. The method of claim 10, wherein said antibodies are selected from the group consisting of polyclonal antisera, polyclonal antibodies, and F(ab), F(ab)′

, F(ab)₂, and F_V fragments thereof.

12. The method of claim 10, wherein said antibodies are selected from the group consisting of monoclonal antibodies, and F(ab), F(ab)′

, F(ab)₂, and F_V, fragments thereof.

13. The method of claim 10, wherein said antibodies are selected from the group consisting of F(ab) fragments and a single-chain F_V fragment.

14. The method of claim 1, wherein said plurality of target binding molecules comprises a library.

15. The method of claim 14, wherein said library is selected from the group consisting of a natural products library, a peptide library, a phage display library, and a combinatorial library.

16. The method of claim 1, wherein said target molecule comprises an electrochemical reporter molecule.

17. The method of claim 16, wherein said reporter molecule comprises a transition metal complex.

18. The method of claim 17, wherein the transition metal ion is selected from the group consisting of ruthenium, cobalt, iron, zinc, copper, magnesium, nickel, and osmium.

19. The method of claim 16, wherein said reporter molecule is selected from the group consisting of 1,4-benzoquinone, ferrocene, tetracyanoquinodimethane, N,N,N′

,N′

-tetramethyl-p-phenylenediamine, and tetrathiafulvalene.

20. The method of claim 16, wherein said reporter molecule is selected from the group consisting of 9-aminoacridine, acridine orange, aclarubicin, daunomycin, doxorubicin, pirarubicin, ethidium bromide, ethidium monoazide, chlortetracycline, tetracycline, minocycline, Hoechst 33258, Hoechst 33342, 7-aminoactinomycin D, Chromomycin A₃, mithramycin A, Vinblastine, Rifampicin, Os(bipyridine)₂(dipyridophenazine)₂⁺, Co(bipyridine)₃³⁺, and Fe-bleomycin.